Trial Profile
Clinical study on the efficacy and safety of telbivudine for interrupting mother-to-child transmission of hepatitis B virus (HBV) in pregnant women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Hepatitis B immune globulin
- Indications Hepatitis B
- Focus Biomarker; Pharmacodynamics
- 25 Apr 2016 New trial record